Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Sargramostim in Patients With COVID-19

ClinicalTrials.gov ID: NCT04411680

Public ClinicalTrials.gov record NCT04411680. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 6:23 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Trial Evaluating Sargramostim in Patients With COVID-19 Associated Acute Hypoxemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this research is to find out if a drug (sargramostim) also known as Leukine® could help patient recover faster from COVID-19. Sargramostim may help the lungs recover from the effects of COVID-19, and this research study will help to find this out.

Study identification

NCT ID
NCT04411680
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Partner Therapeutics, Inc.
Industry
Enrollment
123 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 18, 2020 (Actual)
Primary completion
Mar 2, 2021 (Actual)
Completion
May 19, 2021 (Actual)
Last update posted
Aug 23, 2023

2020 – 2021

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
11
Facility City State ZIP Site status
St. Jude Medical Center Fullerton California 92835 —
St. Joseph Hospital of Orange Orange California 92868 —
California Pacific Medical Center - Van Ness Campus San Francisco California 94109 —
TidalHealth Peninsula Regional, Inc Salisbury Maryland 21801 —
University of Missouri Health Care Columbia Missouri 65212 —
Great Plains Health North Platte Nebraska 69101 —
Richmond University Medical Center Staten Island New York 10310 —
Brody School of Medicine at East Carolina University Greenville North Carolina 27834 —
University of Toledo Medical Center Toledo Ohio 43614 —
Memorial Hermann Hospital Affiliated with the University of Texas Health Science Center at Houston, McGovern Medical School Houston Texas 77030 —
University of Utah Health Salt Lake City Utah 84108 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04411680, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 23, 2023 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04411680 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →